| Eisei Noiri, MD, PhD, FASN Tokyo, JAPAN Eisei NOIRI graduated from Hamamatsu University School of Medicine (HUSM) and received PhD at The University of Tokyo under Prof. Kiyoshi Kurokawa. He spent three years in SUNY Stony Brook and BNL under Prof. Michael Goligorsky. He is one of the chief researchers in Division of Nephrology and head of Department of Hemodialysis and Apheresis in The University of Tokyo Hospital. His research interests are broad from basic sciences in AKI pathophysiology, clinical applicability of biomarkers, epidemiology of CRRT, theoretical consideration to CRRT and apheresis therapy, and more. Since 2019, he appointed as the director general of National Center Biobank Network (NCBN) in Japan. NCBN is responsible for supervising the biobanks attached to six national centers (NCs) in Japan. Currently, the coorporative project between NCs and Pharama, namely GAPFREE4, is running under the support of AMED. He is responsible for coordinating research on target diseases that multiple Japanese pharmaceutical companies are jointly hoping to develop, and is promoting the task of sharing the results in a database after performing multiple OMICS analyses based on biobank resources and prospective patient sample collection. |